Correspondence 0001193125-24-240542 from Oaktree Acquisition Corp. III Life Sciences (OACC, OACCU) (CIK 0002029769) (OACC)
Oaktree Acquisition Corp. III Life Sciences (OACC, OACCU) (CIK 0002029769)
Date: Oct. 21, 2024 · CIK: 0002029769 · Accession: 0001193125-24-240542
AI Filing Summary & Sentiment
File numbers found in text: 333-282508
Letter
Oaktree Acquisition Corp. III Life Sciences
333 South Grand Avenue, 28th Floor
Los Angeles, California 90071
October 21, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate & Construction
100 F Street, N.E.
Washington, D.C. 20549
Attn: Stacie Gorman and Jeffrey Gabor
Re: Oaktree Acquisition Corp. III Life Sciences
Registration Statement on Form S-1, as amended
Initially Filed October 4, 2024
File No. 333-282508
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Oaktree Acquisition Corp. III Life Sciences (the “Company”) hereby requests acceleration of the effective date of the above referenced Registration Statement to 4:30 p.m., Eastern Time, on October 23, 2024, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Kirkland & Ellis LLP, request by telephone that such Registration Statement be declared effective.
Please contact Mathieu Kohmann, of Kirkland & Ellis LLP, special counsel to the Company, at (212) 390-4510, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.
[Signature Page Follows]
Very truly yours,
OAKTREE ACQUISITION CORP. III LIFE SCIENCES
Show Raw Text
CORRESP 1 filename1.htm CORRESP Oaktree Acquisition Corp. III Life Sciences 333 South Grand Avenue, 28th Floor Los Angeles, California 90071 October 21, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Attn: Stacie Gorman and Jeffrey Gabor Re: Oaktree Acquisition Corp. III Life Sciences Registration Statement on Form S-1, as amended Initially Filed October 4, 2024 File No. 333-282508 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Oaktree Acquisition Corp. III Life Sciences (the “Company”) hereby requests acceleration of the effective date of the above referenced Registration Statement to 4:30 p.m., Eastern Time, on October 23, 2024, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Kirkland & Ellis LLP, request by telephone that such Registration Statement be declared effective. Please contact Mathieu Kohmann, of Kirkland & Ellis LLP, special counsel to the Company, at (212) 390-4510, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter. [Signature Page Follows] Very truly yours, OAKTREE ACQUISITION CORP. III LIFE SCIENCES By: /s/ Zaid Pardesi Name: Zaid Pardesi Title: Chief Executive Officer cc: Christian O. Nagler, Kirkland & Ellis LLP Peter Seligson, Kirkland & Ellis LLP Mathieu Kohmann, Kirkland & Ellis LLP